Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women’s Health Initiative observational study

Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays

(2017) Arturo B. Ramirez et al.   Cancer Biomarkers

Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force

(2013) Heidi D. Nelson   ANNALS OF INTERNAL MEDICINE

Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger

(2011) Mia M. Gaudet et al.   BREAST CANCER RESEARCH AND TREATMENT

Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer

(2011) A. I. Phipps et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Novel Prognostic Markers in the Serum of Patients With Castration-Resistant Prostate Cancer Derived From Quantitative Analysis of the Pten Conditional Knockout Mouse Proteome

(2011) Martin Kälin et al.   EUROPEAN UROLOGY

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk

(2010) Amanda I. Phipps et al.   BREAST CANCER RESEARCH AND TREATMENT

Use of Four Biomarkers to Evaluate the Risk of Breast Cancer Subtypes in the Women's Contraceptive and Reproductive Experiences Study

(2010) H. Ma et al.   CANCER RESEARCH

Use of a Single-Chain Antibody Library for Ovarian Cancer Biomarker Discovery

(2010) Arturo B. Ramirez et al.   MOLECULAR & CELLULAR PROTEOMICS

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

(2008) Mary Jo Lund et al.   BREAST CANCER RESEARCH AND TREATMENT

Impact of Triple Negative Phenotype on Breast Cancer Prognosis

(2008) Henry G. Kaplan et al.   Breast Journal

The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004

(2008) Monica Brown et al.   CANCER

Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer

(2008) Amanda I. Phipps et al.   CANCER

Body Size and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer in Postmenopausal Women

(2008) A. I. Phipps et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Basal-Like Breast Cancer: A Critical Review

(2008) Emad A. Rakha et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery

(2008) Nathalie Scholler et al.   Journal of Translational Medicine